SPC466
Fezolinetant
Status:
VeittApplication date:
30.4.2024Application published:
15.5.2024Grant published:
15.11.2025
Max expiry date:
11.12.2038Medicine name:
VEOZAMedicine for children:
No
Timeline
Today
30.4.2024Application
15.5.2024Publication
15.11.2025Registration
11.12.2038Expires
Marketing license
IS authorization number:
EU/1/23/1771Date:
18.12.2023
Foreign authorization number:
EU/1/23/1771Date:
7.12.2023
Owner
Name:
OGEDA NVAddress:
Medialaan 50, Vilvoorde 1800 BE
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105 Reykjavík
Patent
Number:
EP2948455
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 22.11.2025